Form 8-K - Current report:
SEC Accession No. 0001104659-25-065294
Filing Date
2025-07-02
Accepted
2025-07-02 16:16:10
Documents
17
Period of Report
2025-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2519676d1_8k.htm   iXBRL 8-K 31915
2 EXHIBIT 3.1 tm2519676d1_ex3-1.htm EX-3.1 6601
3 EXHIBIT 10.1 tm2519676d1_ex10-1.htm EX-10.1 36970
4 EXHIBIT 99.1 tm2519676d1_ex99-1.htm EX-99.1 12788
8 GRAPHIC tm2519676d1_ex10-1img001.jpg GRAPHIC 3181
9 GRAPHIC tm2519676d1_ex99-1img001.jpg GRAPHIC 4251
  Complete submission text file 0001104659-25-065294.txt   288602

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA hypd-20250630.xsd EX-101.SCH 3026
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE hypd-20250630_lab.xml EX-101.LAB 34915
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hypd-20250630_pre.xml EX-101.PRE 22796
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2519676d1_8k_htm.xml XML 3974
Mailing Address 23461 SOUTH POINTE DRIVE, SUITE 390 LAGUNA HILLS CA 92653
Business Address 23461 SOUTH POINTE DRIVE, SUITE 390 LAGUNA HILLS CA 92653 833-393-6684
HYPERION DEFI, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 251101264
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)